Indication
Klebsiella infection
A Klebsiella infection is an infectious disease caused by Gram-negative, encapsulated bacilli of the genus *Klebsiella*, most commonly *Klebsiella pneumoniae*. Read more about Klebsiella infection
14 drugs 13 manufacturers
Drugs that treat it
Common Klebsiella infection therapies.
COLISTIMETHATE (colistin (as colistimethate sodium))
COLISTIMETHATE (colistin (as colistimethate sodium))
COLISTIMETHATE (colistin (as colistimethate sodium))
COLISTIMETHATE (colistin (as colistimethate sodium))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA Klebsiella infection is an infectious disease caused by Gram-negative, encapsulated bacilli of the genus *Klebsiella*, most commonly *Klebsiella pneumoniae*.
It frequently manifests as a healthcare-associated infection in hospitalized, debilitated, or immunocompromised patients, though hypervirulent strains can cause invasive disease in healthy individuals.
Pathophysiologically, the bacteria utilize prominent polysaccharide capsules, lipopolysaccharides, and siderophores to evade host immune defenses, colonizing mucosal surfaces and disseminating to cause pneumonia, urinary tract infections, intra-abdominal abscesses, wound infections, and bloodstream infections.
Clinical presentations vary by anatomical site and often involve acute inflammation, tissue necrosis, and significant risks associated with multidrug resistance.
- nih.gov
A Klebsiella infection is an infectious disease caused by Gram-negative, encapsulated bacilli of the genus *Klebsiella*, most commonly *Klebsiella pneumoniae* Pathophysiologically, the bacteria utilize prominent polysaccharide capsules, lipopolysaccharides, and siderophores to evade host immune defenses, colonizing mucosal surfaces and disseminating to cause pneumonia, urinary tract infections, intra-abdominal abscesses, wound infections, and bloodstream infections
- nih.gov
A Klebsiella infection is an infectious disease caused by Gram-negative, encapsulated bacilli of the genus *Klebsiella*, most commonly *Klebsiella pneumoniae* It frequently manifests as a healthcare-associated infection in hospitalized, debilitated, or immunocompromised patients, though hypervirulent strains can cause invasive disease in healthy individuals Clinical presentations vary by anatomical site and often involve acute inflammation, tissue necrosis, and significant risks associated with ...
- youtube.com
It frequently manifests as a healthcare-associated infection in hospitalized, debilitated, or immunocompromised patients, though hypervirulent strains can cause invasive disease in healthy individuals
- nih.gov
It frequently manifests as a healthcare-associated infection in hospitalized, debilitated, or immunocompromised patients, though hypervirulent strains can cause invasive disease in healthy individuals Pathophysiologically, the bacteria utilize prominent polysaccharide capsules, lipopolysaccharides, and siderophores to evade host immune defenses, colonizing mucosal surfaces and disseminating to cause pneumonia, urinary tract infections, intra-abdominal abscesses, wound infections, and bloodstream...
- cdc.gov
Clinical presentations vary by anatomical site and often involve acute inflammation, tissue necrosis, and significant risks associated with multidrug resistance
- clevelandclinic.org
Clinical presentations vary by anatomical site and often involve acute inflammation, tissue necrosis, and significant risks associated with multidrug resistance
Personalize your experience
Follow Klebsiella infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.